These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16782993)

  • 21. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microalbuminuria and obesity: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):40-5. PubMed ID: 18803675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diabetes mellitus and cardiovascular risk].
    Valdés F; Lorenzo D; Calviño X; Cao M; Fernández Rivera C; Pérez Fontán M
    Nefrologia; 2001; 21 Suppl 3():52-7. PubMed ID: 11642208
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiovascular disorders in chronic renal failure].
    Bagriĭ AE
    Ter Arkh; 1998; 70(11):80-3. PubMed ID: 9949472
    [No Abstract]   [Full Text] [Related]  

  • 25. Infections and cardiovascular disease in patients with chronic kidney disease.
    Foley RN
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):205-8. PubMed ID: 16815226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular disease in chronic renal failure. Risk factors and prevention.
    Henriquez D; Dikow R; Ritz E
    Nefrologia; 2004; 24 Suppl 4():34-9. PubMed ID: 15279384
    [No Abstract]   [Full Text] [Related]  

  • 27. The case for using albuminuria in staging chronic kidney disease.
    Gansevoort RT; de Jong PE
    J Am Soc Nephrol; 2009 Mar; 20(3):465-8. PubMed ID: 19255126
    [No Abstract]   [Full Text] [Related]  

  • 28. Classic risk factors for cardiovascular disease in chronic kidney disease.
    De Santo NG; Cirillo M; Iacono G; Capasso G
    Semin Nephrol; 2005 Nov; 25(6):357. PubMed ID: 16298254
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diabetes worsens the clinical manifestations and prognosis of concurrent cardiovascular and kidney disease].
    Leo R; Tesauro M; Forleo GB; Razzini C; Romeo F; Lauro R
    G Ital Nefrol; 2009; 26 Suppl 46():71-8. PubMed ID: 19644822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease and cardiovascular disease: a case presentation.
    McCarley PB; Salai PB
    Nephrol Nurs J; 2007; 34(2):187-98; quiz 199-200. PubMed ID: 17486949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reverse epidemiology in chronic kidney disease: beyond traditional explanations].
    Massy ZA
    Nephrol Ther; 2008 Jul; 4(4):221-2. PubMed ID: 18485857
    [No Abstract]   [Full Text] [Related]  

  • 33. Microalbuminuria: risk factor and potential therapeutic target for stroke?
    Ovbiagele B
    J Neurol Sci; 2008 Aug; 271(1-2):21-8. PubMed ID: 18514228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal disease, homocysteine, and cardiovascular complications.
    Robinson K
    Circulation; 2004 Jan; 109(3):294-5. PubMed ID: 14744952
    [No Abstract]   [Full Text] [Related]  

  • 35. Has the time come for a new definition of microalbuminuria?
    Karagiannis A; Mikhailidis DP; Tziomalos K; Kakafika AI; Athyros VG
    Curr Vasc Pharmacol; 2008 Apr; 6(2):81-3. PubMed ID: 18393908
    [No Abstract]   [Full Text] [Related]  

  • 36. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Q & A: ask the experts. An interview with Joseph Eustace.
    Eustace J
    Nephrol News Issues; 2005 Mar; 19(4):S7. PubMed ID: 15813316
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
    Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
    Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of microalbuminuria in the overall risk assessment of hypertensive patients].
    Leoncini G; Ratto E; Viazzi F; Pontremoli R
    G Ital Nefrol; 2007; 24(6):565-73. PubMed ID: 18278760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.